 Immunoassay
"Immunoassay" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A technique using antibodies for identifying or quantifying a substance. Usually the substance being studied serves as antigen both in antibody production and in measurement of antibody by the test substance.
| Descriptor ID |
D007118
|
| MeSH Number(s) |
E05.478.566 E05.601.495
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Immunoassay".
Below are MeSH descriptors whose meaning is more specific than "Immunoassay".
This graph shows the total number of publications written about "Immunoassay" by people in this website by year, and whether "Immunoassay" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1983 | 0 | 2 | 2 | | 1984 | 0 | 1 | 1 | | 1985 | 0 | 1 | 1 | | 1987 | 0 | 2 | 2 | | 1988 | 0 | 2 | 2 | | 1989 | 0 | 3 | 3 | | 1991 | 0 | 1 | 1 | | 1992 | 1 | 0 | 1 | | 1995 | 1 | 0 | 1 | | 1997 | 1 | 1 | 2 | | 1998 | 0 | 2 | 2 | | 1999 | 0 | 2 | 2 | | 2000 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 2003 | 3 | 0 | 3 | | 2004 | 0 | 1 | 1 | | 2005 | 0 | 1 | 1 | | 2007 | 0 | 1 | 1 | | 2008 | 0 | 2 | 2 | | 2009 | 2 | 1 | 3 | | 2010 | 0 | 2 | 2 | | 2011 | 1 | 4 | 5 | | 2012 | 0 | 1 | 1 | | 2013 | 2 | 2 | 4 | | 2014 | 1 | 0 | 1 | | 2015 | 0 | 2 | 2 | | 2016 | 0 | 1 | 1 | | 2017 | 3 | 1 | 4 | | 2018 | 1 | 0 | 1 | | 2019 | 2 | 1 | 3 | | 2020 | 3 | 2 | 5 | | 2021 | 0 | 2 | 2 | | 2022 | 0 | 2 | 2 | | 2023 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoassay" by people in Profiles.
-
Dasgupta A, Yeo KJ. Biotin Interference in Immunoassays and Patient Safety. Am J Clin Pathol. 2023 01 04; 159(1):1-2.
-
Sigal GB, Novak T, Mathew A, Chou J, Zhang Y, Manjula N, Bathala P, Joe J, Padmanabhan N, Romero D, Allegri-Machado G, Joerger J, Loftis LL, Schwartz SP, Walker TC, Fitzgerald JC, Tarquinio KM, Zinter MS, Schuster JE, Halasa NB, Cullimore ML, Maddux AB, Staat MA, Irby K, Flori HR, Coates BM, Crandall H, Gertz SJ, Randolph AG, Pollock NR. Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay. Clin Infect Dis. 2022 10 12; 75(8):1351-1358.
-
Chan SL, Refetoff S, Babic N, Jin M, Garg U, Yeo KJ. Triiodothyroacetic Acid Cross-Reacts With Measurement of Triiodothyronine (T3) on Various Immunoassay Platforms. Am J Clin Pathol. 2022 02 03; 157(2):156-158.
-
Sancilio AE, D'Aquila RT, McNally EM, Velez MP, Ison MG, Demonbreun AR, McDade TW. A surrogate virus neutralization test to quantify antibody-mediated inhibition of SARS-CoV-2 in finger stick dried blood spot samples. Sci Rep. 2021 07 28; 11(1):15321.
-
El Jaddaoui I, Allali M, Raoui S, Sehli S, Habib N, Chaouni B, Al Idrissi N, Benslima N, Maher W, Benrahma H, Hamamouch N, El Bissati K, El Kasmi S, Hamdi S, Bakri Y, Nejjari C, Amzazi S, Ghazal H. A review on current diagnostic techniques for COVID-19. Expert Rev Mol Diagn. 2021 02; 21(2):141-160.
-
McDade TW, Miller A, Tran TT, Borders AEB, Miller G. A highly sensitive multiplex immunoassay for inflammatory cytokines in dried blood spots. Am J Hum Biol. 2021 11; 33(6):e23558.
-
Yoh KE, Lowe CJ, Mahajan S, Suttmann R, Nguy T, Reichelt M, Yang J, Melendez R, Li Y, Molinero L, Ruppel J, Xu W, Plaks V. Enrichment of circulating tumor-derived extracellular vesicles from human plasma. J Immunol Methods. 2021 03; 490:112936.
-
Tang NY, Yeo KJ, van Wijk XMR. Evaluation of interference effects from hemolysis, icterus and lipemia on the Roche Elecsys? Anti-SARS-CoV-2 assay. Clin Chim Acta. 2020 Oct; 509:293-294.
-
Deak P, Kimani F, Cassaidy B, Esser-Kahn A. Determining Whether Agonist Density or Agonist Number Is More Important for Immune Activation via Micoparticle Based Assay. Front Immunol. 2020; 11:642.
-
Tang NY, Groboske SE, Baldwin AD, Yeo KJ, van Wijk XMR. False-Positive Hepatitis B Surface Antibody Results: An Example of Reagent Carryover. J Appl Lab Med. 2020 03 01; 5(2):429-431.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|